Regulators of PPARdelta(beta) and their use in the treatment of obesity and insulin resistance

Details for Australian Patent Application No. 2001277926 (hide)

Owner Bristol-Myers Squibb Company

Inventors Hariharan, Narayanan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001277926

PCT Pub. Number WO02/07765

Priority 60/219,956 20.07.00 US

Filing date 19 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 16 February 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

16 February 2006 Application Accepted

  Published as AU-B-2001277926

22 June 2006 Standard Patent Sealed

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001277927-DEVICE FOR INSERTING FILL MATERIAL PARTICLES INTO BODY CAVITIES

2001277925